Feasibility of Early Surgical Treatment for Adolescent Patients with Prolactinoma: A Case Report and Literature Review.
Yu-Hung TsaiChi-Ruei LiYu-Ting WangSe-Yi ChenPublished in: Medicina (Kaunas, Lithuania) (2024)
Background and Objectives : Prolactinomas are the most common pituitary adenomas, comprising 30-50% of such tumors. These adenomas cause hyperprolactinemia, leading to decreased fertility, reduced energy and libido, and galactorrhea. Diagnosing and treating prolactinomas in adolescents present unique challenges, as symptoms may be confused with age-related developmental variations. This case report explores the outcomes of early surgical intervention in an adolescent with a prolactinoma. Materials and Methods : A 14-year-old female presented delayed menarche and absent pubertal development. Initial evaluation revealed hyperprolactinemia (228.37 ng/mL) with normal estradiol levels. Initial management through observation was adopted, but persistent amenorrhea and severe headaches prompted further investigation. Magnetic resonance imaging revealed a cystic pituitary mass with apoplexy. Due to concerns regarding delayed puberty and the need for rapid normalization of prolactin levels, the patient underwent transsphenoidal surgery. Results: After operation, prolactin levels normalized, menarche occurred within three months, and secondary sexual characteristics developed within eight months. Pathology confirmed a pituitary adenoma with a high Ki-67 index (15%). Conclusions : Early surgical intervention for prolactinomas in adolescents can achieve successful biochemical remission and resolution of endocrine symptoms. Adolescents, particularly those with a high Ki-67 index and potential resistance to dopamine agonists, may benefit from prompt surgical management, resulting in improved clinical outcomes and complete tumor resection.
Keyphrases
- young adults
- case report
- magnetic resonance imaging
- growth hormone
- physical activity
- mental health
- randomized controlled trial
- childhood cancer
- minimally invasive
- neoadjuvant chemotherapy
- rheumatoid arthritis
- early onset
- squamous cell carcinoma
- coronary artery bypass
- disease activity
- climate change
- magnetic resonance
- insulin resistance
- risk assessment
- lymph node
- skeletal muscle
- estrogen receptor
- diffusion weighted imaging
- drug induced
- clinical evaluation